Heterocyclic glutaminase inhibitors
US10793535B2 · kind B2 · utility
1Cited by
10References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2013 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Nov 12, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.